We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$75M |
| 2 |
Biogen
BIIB
|
+$70.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$60.1M |
| 4 |
Merck
MRK
|
+$54.6M |
| 5 |
Gilead Sciences
GILD
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$19.1M |
| 2 |
IRBT
iRobot
IRBT
|
+$15.5M |
| 3 |
Quest Diagnostics
DGX
|
+$15.4M |
| 4 |
Colgate-Palmolive
CL
|
+$14.8M |
| 5 |
Philip Morris
PM
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.26% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Edison International
EIX
$30.7B
| $12.8M | 0.17% |
188,897
-31,851
| -14% | -$2.13M |
|
152
Bank of America
BAC
$435B
| $12.8M | 0.17% |
433,939
-76,474
| -15% | -$2.33M |
|
153
WEX
WEX
$6.11B
| $12.8M | 0.17% |
63,574
+21,079
| +50% | +$4.04M |
|
154
Molson Coors Class B
TAP
$7.68B
| $12.7M | 0.17% |
206,285
+39,669
| +24% | +$2.62M |
|
155
Qorvo
QRVO
$7.63B
| $12.4M | 0.17% |
161,709
+77,582
| +92% | +$6.21M |
|
156
Universal Health Services
UHS
$9.43B
| $12.4M | 0.16% |
96,802
+31,898
| +49% | +$3.92M |
|
157
Travelers Companies
TRV
$80.8B
| $12.1M | 0.16% |
92,907
-84,803
| -48% | -$10.9M |
|
158
Royal Bank of Canada
RY
$291B
| $12M | 0.16% |
149,645
-10,447
| -7% | -$819K |
|
159
Universal Display
OLED
$3.71B
| $11.9M | 0.16% |
100,932
+19,945
| +25% | +$2.19M |
|
|
ITCI
160
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $11.9M | 0.16% |
548,000
+311,000
| +131% | +$6.5M |
|
161
Southwest Airlines
LUV
$22.1B
| $11.7M | 0.16% |
187,943
-84,527
| -31% | -$4.94M |
|
162
Netflix
NFLX
$292B
| $11.7M | 0.16% |
312,070
-17,830
| -5% | -$647K |
|
163
Ameriprise Financial
AMP
$46.8B
| $11.5M | 0.15% |
77,948
+1,779
| +2% | +$255K |
|
164
Occidental Petroleum
OXY
$57B
| $11.5M | 0.15% |
140,060
-113,629
| -45% | -$9.18M |
|
165
Nike
NKE
$61.9B
| $11.5M | 0.15% |
135,510
+3,026
| +2% | +$243K |
|
166
Fastenal
FAST
$54B
| $11.4M | 0.15% |
786,632
-95,608
| -11% | -$1.36M |
|
167
Regions Financial
RF
$26.3B
| $11.4M | 0.15% |
620,257
-57,221
| -8% | -$1.08M |
|
168
Toronto Dominion Bank
TD
$198B
| $11.4M | 0.15% |
187,433
-5,892
| -3% | -$351K |
|
169
Bio-Rad Laboratories Class A
BIO
$8.42B
| $11.3M | 0.15% |
36,250
+15,850
| +78% | +$4.92M |
|
|
SPPI
170
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $11.2M | 0.15% |
669,100
+374,600
| +127% | +$8.11M |
|
171
Stryker
SYK
$127B
| $11.2M | 0.15% |
63,002
-307
| -0.5% | -$52.4K |
|
172
Electronic Arts
EA
$52.4B
| $11.2M | 0.15% |
92,801
+22,212
| +31% | +$2.86M |
|
173
Boeing
BA
$165B
| $11.1M | 0.15% |
29,820
-3,380
| -10% | -$1.19M |
|
174
Synchrony
SYF
$23.7B
| $11M | 0.15% |
352,869
+13,522
| +4% | +$431K |
|
175
Unum
UNM
$13.8B
| $10.9M | 0.15% |
279,412
-13,360
| -5% | -$498K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2018 Portfolio in Review
As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.
- Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
- Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
- Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
- Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
- Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
- Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.
Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.